Laboratorio Reig Jofre (XMAD:RJF) 3-Year Revenue Growth Rate : 10.30% (As of Dec. 2023)

View and export this data going back to 2006. Start your Free Trial

What is Laboratorio Reig Jofre 3-Year Revenue Growth Rate?

Laboratorio Reig Jofre's Revenue per Share for the three months ended in Dec. 2023 was €1.00.

During the past 12 months, Laboratorio Reig Jofre's average Revenue per Share Growth Rate was 16.70% per year. During the past 3 years, the average Revenue per Share Growth Rate was 10.30% per year. During the past 5 years, the average Revenue per Share Growth Rate was 7.50% per year. During the past 10 years, the average Revenue per Share Growth Rate was 13.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of Laboratorio Reig Jofre was 153.10% per year. The lowest was -54.90% per year. And the median was 5.10% per year.

Competitive Comparison of Laboratorio Reig Jofre's 3-Year Revenue Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Laboratorio Reig Jofre's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Laboratorio Reig Jofre's 3-Year Revenue Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Laboratorio Reig Jofre's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Laboratorio Reig Jofre's 3-Year Revenue Growth Rate falls into.

Laboratorio Reig Jofre 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

Laboratorio Reig Jofre (XMAD:RJF) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

Laboratorio Reig Jofre 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Laboratorio Reig Jofre's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Laboratorio Reig Jofre (XMAD:RJF) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Laboratorio Reig Jofre SA (XMAD:RJF) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

FEQ1:Germany

Address

Avenida de les Flors, Sant Joan Despi, Barcelona, ESP, 08970

Website

http://www.reigjofre.com

Laboratorio Reig Jofre SA is a healthcare and pharmaceutical developing company. The company focuses on the development of technological-specialization products (antibiotics and injectable products); therapeutic-specialization products in the areas of dermatology, gynecology and respiratory; and consumer healthcare products. It has a broad portfolio of products that the company divides into three categories: products from specialized technology such as antibiotics, injectable, and freeze-dried products.